Ligand Pharmaceuticals Inc (LGND)
Deferred Revenue
$621.00K
Quarterly · Period ending: · USD
LGND Deferred Revenue
Latest reported$621.00Kperiod ending
Latest reported$621.00Kperiod ending
LGND Quarterly Deferred Revenue ($0.00 → $621.00K)
Quarterly deferred revenue
High-resolution chart · PNG
LGND deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 621,000 | |
| 621,000 | |
| 621,000 | |
| 135,000 | |
| 732,000 | |
| 722,000 | |
| 1,899,000 | |
| 1,773,000 | |
| 1,817,000 | |
| 1,848,000 | |
| 1,843,000 | |
| 621,000 | |
| 621,000 | |
| 257,000 | |
| 976,000 | |
| 9,547,000 | |
| 10,584,000 | |
| 10,503,000 | |
| 654,000 | |
| 12,007,000 | |
| 17,147,000 | |
| 25,107,000 | |
| 29,435,000 | |
| 5,404,000 | |
| 8,917,000 | |
| 4,354,000 | |
| 2,139,000 | |
| 2,230,000 | |
| 939,000 | |
| 2,808,000 | |
| 3,286,000 | |
| 2,450,000 | |
| 1,700,000 | |
| 75,000 | |
| 173,000 | |
| 1,075,000 | |
| 0 | |
| 4,680,000 | |
| 123,891,000 | |
| -1,505,000 | |
| 4,951,000 | |
| -577,000 | |
| 216,564,000 | |
| 2,083,000 | |
| 2,083,000 | |
| 67,000 | |
| 150,000 | |
| 114,000 | |
| 92,000 | |
| 2,085,000 | |
| 116,000 | |
| 336,000 | |
| 452,000 | |
| 556,000 | |
| 486,000 | |
| 458,000 | |
| 412,000 | |
| 727,000 | |
| 1,240,000 | |
| 426,000 | |
| 889,000 | |
| 1,304,000 | |
| 1,702,000 | |
| 1,702,000 | |
| 2,663,000 | |
| 6,025,000 | |
| 6,691,000 | |
| 12,626,000 | |
| 12,223,000 | |
| 12,156,000 | |
| 12,265,000 | |
| 2,546,000 | |
| 1,964,000 | |
| 1,964,000 | |
| 1,964,000 | |
| 1,964,000 | |
| 1,964,000 | |
| 1,964,000 | |
| 59,945,000 | |
| 80,395,000 | |
| 143,102,000 | |
| 151,021,000 | |
| 157,519,000 | |
| 158,224,000 | |
| 153,372,000 | |
| 152,938,000 | |
| 152,528,000 | |
| 2,352,000 | |
| 2,381,000 | |
| 2,346,000 | |
| 2,564,000 | |
| 3,502,000 | |
| 4,126,000 | |
| 4,637,000 | |
| 4,683,000 | |
| 3,319,000 | |
| 10,302,000 | |
| 7,415,000 | |
| 8,729,000 | |
| 10,043,000 |